Data as of .
BUYZ vs FMED: which is really different?
BUYZ and FMED hold 0% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: FMED scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, BUYZ and FMED hold 0% of their money in the same securities at the same weight.
| Only in BUYZ | Only in FMED |
|---|---|
| AMAZON.COM INC 11.18% | UCB SA 4.75% |
| SHOPIFY INC 8.57% | LIFESTANCE HEALTH GROUP INC 4.29% |
| APPLOVIN CORP 5.39% | DANAHER CORP 3.43% |
| ALPHABET INC 4.08% | 10X GENOMICS INC 3.12% |
| META PLATFORMS INC 3.95% | INTUITIVE SURGICAL INC 2.93% |
| CARVANA COMPANY 3.70% | COGENT BIOSCIENCES INC 2.86% |
| DOORDASH INC 3.35% | ALNYLAM PHARMACEUTICALS INC 2.80% |
| EBAY INC 3.32% | ARGENX SE 2.79% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| BUYZ | FMED | BUYZ | FMED | BUYZ | FMED | |
| 3 months | +1.8% | +21.3% | −0.4 pts | +19.0 pts | +4.3 pts | +23.7 pts |
| 6 months | +7.8% | +32.3% | −10.2 pts | +14.3 pts | −16.4 pts | +8.0 pts |
| 1 year | −22.6% | +28.3% | −39.1 pts | +11.7 pts | −44.3 pts | +6.5 pts |
| 3 years | +36.9% | +39.6% | −41.5 pts | −38.8 pts | −61.3 pts | −58.5 pts |
| Since launch | +42.6% | +25.8% | −140.3 pts | −57.6 pts | −222.0 pts | −78.1 pts |
| BUYZ Franklin Disruptive Commerce ETF Holds 58 stocks in broad innovation and megatrends, 62% of its weight in S&P 500 companies | FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Franklin | Fidelity |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 62.5% | 25.4% |
| Active share vs the S&P 500 | 86.3% | 97.1% |
| In the Nasdaq-100 | 54.0% | 8.7% |
| Holdings | 58 | 68 |
| Top ten, share of the fund | 50.0% | 31.5% |
| Expense ratio | 0.50% | 0.50% |
| Fee for the differing part | 0.58% | 0.51% |
| Total return, 1 year | −22.6% | +28.3% |
| vs the S&P 500 | −39.1 pts | +11.7 pts |
| vs the Nasdaq-100 | −44.3 pts | +6.5 pts |
| Below its high | −44.5% | −3.8% |
| Net assets | $5m | $52m |
BUYZ in plain words
By weight, 62% of BUYZ's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 86%. The top ten holdings are 50% of the fund across 58 positions, as filed for Jun 30, 2026. Over the year to Sep 18, 2026 the fund returned −22.6% with distributions reinvested against +16.6% for the S&P 500, so a holder was behind by 39.1 pts. It sits 44.5% below its all-time high of Feb 12, 2021.
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
Questions people ask
- Do BUYZ and FMED hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, BUYZ or FMED?
- BUYZ has 62% of its weight in S&P 500 names and FMED has 25%, so FMED differs more from the index.
- Which is cheaper, BUYZ or FMED?
- BUYZ charges 0.50% a year and FMED charges 0.50%, so BUYZ is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BUYZ against FMED, data as of Sep 18, 2026. https://etfiq.com/compare/themes/buyz-vs-fmed Free to use with attribution; the underlying files are at Open data.